tacrolimus
UkraineDrugs containing this active substance
-
The drug is used for the prevention and treatment of liver or kidney transplant rejection in adult patients, as well as for the treatment of rejection that is resistant to standard immunosuppressive therapy.
Form: capsules, extended-release
Active substance Dosage tacrolimus 0.5 mg ATC: L04AD02
Manufacturer: Astellas Ireland Co. Ltd
-
The drug is used for the prevention and treatment of liver or kidney transplant rejection in adult patients, as well as for the treatment of rejection that is resistant to standard immunosuppressive therapy.
Form: capsules, extended-release
Active substance Dosage tacrolimus 1 mg ATC: L04AD02
Manufacturer: Astellas Ireland Co. Ltd
-
The drug is used for the prevention and treatment of liver or kidney transplant rejection in adult patients, as well as for the treatment of rejection that is resistant to standard immunosuppressive therapy.
Form: capsules, extended-release
Active substance Dosage tacrolimus 5 mg ATC: L04AD02
Manufacturer: Astellas Ireland Co. Ltd
-
The drug is used for the prevention and treatment of liver or kidney transplant rejection in adult patients, as well as for the treatment of rejection that is resistant to standard immunosuppressive therapy.
Form: capsules, extended-release
Active substance Dosage tacrolimus 3 mg ATC: L04AD02
Manufacturer: Astellas Ireland Co. Ltd
-
The drug is used for the prevention and treatment of liver or kidney transplant rejection in adult patients. It may also be used to treat rejection that is resistant to standard immunosuppressive therapy.
Form: capsules, extended-release
Active substance Dosage tacrolimus 1 mg ATC: L04AD02
Manufacturer: Lek Pharmaceuticals d.d. (primary and secondary packaging, batch release; batch control (only microbiological))
-
The drug is used for the prevention and treatment of liver or kidney transplant rejection in adult patients, as well as for the treatment of rejection that is resistant to standard immunosuppressive therapy.
Form: capsules, extended-release
Active substance Dosage tacrolimus 3 mg ATC: L04AD02
Manufacturer: Lek Pharmaceuticals d.d. (primary and secondary packaging, batch release; batch control (only microbiological))
-
The drug is used for the prevention and treatment of liver or kidney transplant rejection in adult patients, as well as for the treatment of rejection that is resistant to standard immunosuppressive therapy.
Form: capsules, extended-release
Active substance Dosage tacrolimus 5 mg ATC: L04AD02
Manufacturer: Lek Pharmaceuticals d.d. (primary and secondary packaging, batch release; batch control (only microbiological))
-
The drug is used for the prevention and treatment of liver or kidney transplant rejection in adult patients. It may also be used to treat rejection that is resistant to standard immunosuppressive therapy.
Form: capsules, extended-release
Active substance Dosage tacrolimus 0.5 mg ATC: L04AD02
Manufacturer: Lek Pharmaceuticals d.d. (primary and secondary packaging, batch release; batch control (only microbiological))
-
The drug is used for the prevention and treatment of liver, kidney, and heart transplant rejection, as well as for the treatment of rejection that is resistant to other immunosuppressive therapies.
Form: solution for injection, concentrate for preparation of intravenous solution
Active substance Dosage tacrolimus 5 mg/ml ATC: L04AD02
Manufacturer: Astellas Ireland Co., Ltd.
-
The drug is used to prevent rejection following liver, kidney, or heart transplantation, as well as to treat organ rejection if it has already begun and is unresponsive to other treatments.
Form: capsules, hard
Active substance Dosage tacrolimus 0.5 mg ATC: L04AD02
Manufacturer: Astellas Ireland Co. Ltd
-
The drug is used to prevent rejection following liver, kidney, or heart transplantation, as well as to treat organ rejection if it has already occurred and is unresponsive to other treatments.
Form: capsules, hard
Active substance Dosage tacrolimus 1 mg ATC: L04AD02
Manufacturer: Astellas Ireland Co. Ltd
-
The drug is used to prevent rejection following liver, kidney, or heart transplantation, as well as to treat organ rejection if it has already occurred and is unresponsive to other treatments.
Form: capsules, hard
Active substance Dosage tacrolimus 5 mg ATC: L04AD02
Manufacturer: Astellas Ireland Co. Ltd
-
The drug is used for the treatment of moderate to severe atopic dermatitis. It is used both to overcome exacerbations and to prevent new disease flare-ups in children (from 2 years old) and adults.
Form: ointment
Active substance Dosage tacrolimus 0.3 mg/g ATC: D11AH01
Manufacturer: LEO Laboratories Limited (full-cycle manufacturing)
-
The drug is used for the treatment of moderate to severe atopic dermatitis. It is applied both to manage exacerbations and to prevent new recurrences in children (from 2 years of age) and adults.
Form: ointment
Active substance Dosage tacrolimus 1 mg/g ATC: D11AH01
Manufacturer: LEO Laboratories Limited (full-cycle manufacturing)
-
It is used for the prevention of organ rejection (liver, kidney, or heart) after transplantation, as well as for the treatment of rejection cases that do not respond to other immunosuppressive agents.
Form: capsules, hard
Active substance Dosage tacrolimus 5 mg ATC: L04AD02
Manufacturer: Panacea Biotek Pharma Ltd.
-
The drug is used to prevent organ rejection (liver, kidney, or heart) after transplantation, as well as to treat cases of rejection that do not respond to other immunosuppressive agents.
Form: capsules, hard
Active substance Dosage tacrolimus 0.5 mg ATC: L04AD02
Manufacturer: Panacea Biotek Pharma Ltd.
-
The drug is used to prevent organ rejection (liver, kidney, or heart) after transplantation, as well as to treat cases of rejection that do not respond to other immunosuppressive agents.
Form: capsules, hard
Active substance Dosage tacrolimus 1 mg ATC: L04AD02
Manufacturer: Panacea Biotek Pharma Ltd.
-
The drug is used for the prevention and treatment of liver or kidney transplant rejection in adult patients, as well as for the treatment of rejection that is resistant to standard immunosuppressive therapy.
Form: capsules, extended-release, hard
Active substance Dosage tacrolimus 0.5 mg ATC: L04AD02
Manufacturer: JSC Pharmaceutical Plant Teva
-
The drug is used for the prevention and treatment of liver or kidney transplant rejection in adult patients, as well as for the treatment of rejection that is resistant to standard immunosuppressive therapy.
Form: capsules, extended-release, hard
Active substance Dosage tacrolimus 1 mg ATC: L04AD02
Manufacturer: JSC Pharmaceutical Plant Teva
-
The drug is used for the prevention and treatment of liver or kidney transplant rejection in adult patients, as well as for the treatment of rejection that is resistant to standard immunosuppressive therapy.
Form: capsules, extended-release, hard
Active substance Dosage tacrolimus 3 mg ATC: L04AD02
Manufacturer: JSC Pharmaceutical Plant Teva
-
The drug is used for the prevention and treatment of liver or kidney transplant rejection in adult patients, as well as for the treatment of rejection that is resistant to standard immunosuppressive therapy.
Form: capsules, extended-release, hard
Active substance Dosage tacrolimus 5 mg ATC: L04AD02
Manufacturer: JSC Pharmaceutical Plant Teva